PDF(1155 KB)
PDF(1155 KB)
PDF(1155 KB)
血小板及其调控因子在幼兔免疫性血管炎中的动态变化
Roles of platelet and its regulating factors in immune vasculitis in young rabbits
目的：动态观察血小板、巨核细胞、血小板生成素（TPO）、转化生长因子β1（TGF-β1）在幼兔免疫性血管炎模型中的变化及作用机制。方法：用牛血清白蛋白复制幼兔免疫性血管炎的川崎病（KD）动物模型,每隔4 d分别检测血小板计数、巨核细胞计数及分类、TPO水平、TGF-β1阳性率和积分值，并于第17，28天取冠状动脉、肝、脾、肾、脑等组织作病理学分析。结果：实验组血小板、巨核细胞总数、产板巨核细胞百分数于第12，16，20，24，28天, TPO水平于第8，12，16，20，28天, TGF-β1阳性率和积分值于第16，20，24，28天较正常对照组明显升高(P<0.05)。实验组幼兔第17天各组织病理检查可见微小动脉明显的炎性损伤改变，第28天可见中小动脉明显的炎性损伤改变，而主动脉仅见轻度改变。结论：血小板、巨核细胞、TPO、TGF-β1共同参与KD的发病机制，在KD的病理生理过程中发挥重要作用, 提示其均可作为监测KD病情变化的重要指标。［中国当代儿科杂志，2009，11（10）：850-853］
OBJECTIVE: To study the roles of platelet (PLT) and its regulating factors, megakaryocyte, thrombopoietin (TPO) and transforming growth factor β1 (TGF-β1), in immune vasculitis in young rabbits. METHODS: An experimental model of Kawasaki disease (KD) of weanling rabbits was reproduced by bovine serum. PLT count, total number and differentiating count of megakaryocyte, and serum TPO and TGF-β1 levels were measured 0, 4, 8, 12, 16, 20, 24 and 28 days after KD induction. Pathological analysis of coronary artery, liver, spleen, kidney and brain was performed 17 and 28 days after KD induction. RESULTS: In the KD group, PLT count, the total number of megakaryocyte, and the middle board megakaryocyte percentage increased 12, 16, 20, 24 and 28 days; serum TPO level increased 8, 12, 16, 20, 24 and 28 days; serum TGF-β1 level increased 16, 20, 24 and 28 days after KD induction compared with those in the normal control group (P<0.05). The pathological examinations of coronary artery, liver, spleen, kidney and brain showed severe inflammatory injuries of tiny arteries and small/medium-sized arteries 17 and 28 days after KD induction, respectively in the KD group. The aortas were showed as mild inflammatory injuries. CONCLUSIONS: PLT, megakaryocyte, TPO and TGF-β1 participate in the pathogenesis of KD, and they may play an important role in the injuries of immune vasculitis. This suggests that they may serve as markers for the assessment of severity in KD.［Chin J Contemp Pediatr, 2009, 11 (10):850-853］
川崎病 / 血小板 / 巨核细胞 / 血小板生成素 / 转化生长因子β1 / 兔
Kawasaki disease / Platelet / Megakaryocyte / Thrombopoietin / Transforming growth factor β1 / Rabbits
［1］Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association［J］. Pediatrics, 2004, 114(6):1708-1733.
［2］Hamada H, Terai M, Honda T, Kohno Y. Marked pleural and pericardial effusion with elevated vascular endothelial growth factor production:an uncommon complication of Kawasaki disease［J］. Pediatr Int, 2005, 47(1):112-114.
［3］赵琳,夏晓玲,李琳霞.川崎病患儿急性期冠脉扩张与血小板参数变化关系的研究［J］.昆明医学院学报, 2007, 27(2):105-107.
［4］何云,魏枉书,杨锡强.川崎病的动物模型及其发病机制研究进展［J］.国际儿科学杂志, 2007, 34(1):64-66.
［5］Onouchi Z, Ikuta K, Nagamatsu K, Tamiya H, Sakakibara Y, Ando M. Coronary artery aneurysms develop in weanling rabbits with serum sickness but not in mature rabbits.An experimental model for Kawasaki disease in humans［J］. Angidogy, 1995, 46(8):679-687.
［6］胡亚美,江载芳.实用儿科学［M］.第6版.北京:人民卫生出版社,2002，655.
［7］Cummings C, McCarthy P, VanHoff J, Porter G Jr. Kawasaki disease associated with reactive hemophagocytic lymphohistiocytosis［J］. Pediatr Infect Dis J, 2008, 27(12):1116-1118.
［8］梁春杰.川崎病患儿血小板参数的变化及意义［J］.中国现代医学杂志, 2004, 14(22):90-94.
［9］Hitchcock IS, Fox NE, Prévost N, Sear K, Shattil SJ, Kaushansky K. Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function:studies using a megakaryocyte lineage specific FAK knockout［J］. Blood, 2008, 111(2):596-604.
［10］Ishiguro A, Ishikita T, Shimbo T. Elevation of serum thrombopoietin precedes thrombocytosis in Kawasaki disease［J］.Thromb Haemost, 1998, 79(6):1096-1100.
［11］Miura N, Terai M, Meng YG. Serum thrombopoietin levels in Kawasaki disease［J］.Br J Haematol, 1998, 100(2):387-388.
［12］Terai M, Yasukawa K, Narumoto S, Tateno S, Oana S, Kohno Y. Vascular endothelial growth factor in acute Kawasaki disease［J］.Am J Cardiol, 1999, 83(11):1592.
［13］卢巧.川崎病患儿急性期TGF-β1、IL-12及IL-1β的研究［J］.湖北民族学院学报（医学版）, 2007, 24(4):5-7.
［14］白松婷,袁志喜,赵晓明,邹湘，盛光耀.TPO、TSP-1和TGF-β1在特发性血小板减少性紫患儿骨髓表达的改变及其意义［J］.中国小儿血液与肿瘤杂志, 2006, 11(4):198-200.
［15］Akiyama T, Matsunaga T, Temi T, Miyanishi K, Tanaka I, Sato T, et al. Involvement of transforming growth factor-beta and thrombopoietin in the pathogenesis of mydlodysptastic syndrome with myelofibrosis［J］.Leukemia, 2005, 19(9):1558-1566.
［16］Suganami Y, Kawashima H, Hasegawa D, Sato S, Hoshika A. Clinical application of rapid assay of serum interleukin-6 in Kawasaki disease［J］.Pediatr Int, 2008, 50(2):264-266.
［17］史宏,李晓辉,冉丛兰,李丹,徐鸣,周敏,等.川崎病患儿血清IL-3、IL-6、TPO水平变化研究［J］.血栓与止血学, 2008, 14(3):121-123.
［18］Wang H, Wang H, Cheng P. Effects of serum of Kawasaki disease on PDGF expression in monocytes and on endothelial cell apoptosis［J］.J Tongji Med Univ, 1999, 19(2):105-107.
